Monoclonal B-cell lymphocytosis: Update on diagnosis, clinical outcome, and counseling

Clinical Advances in Hematology and Oncology

Volumn 11, Issue 11, 2013, Pages 720-729

  Parikh, Sameer A ^a   Kay, Neil E ^a   Shanafelt, Tait D ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Chronic lymphocytic leukemia; Classifcation; Clinical management; Diagnosis; Monoclonal B cell lymphocytosis

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; NOTCH1 RECEPTOR;

ARTICLE; CELL COUNT; CHROMOSOME REARRANGEMENT; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; FOLLOW UP; GENE MUTATION; HUMAN; INFECTION; LYMPHADENOPATHY; MONOCLONAL B CELL LYMPHOCYTOSIS; PHENOTYPE; PREVALENCE; RECURRENCE RISK; RISK FACTOR; SPLENOMEGALY; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; B LYMPHOCYTE; CELL CLONE; LYMPHOCYTOSIS; PATHOLOGY;

B-LYMPHOCYTES; CLONE CELLS; HUMANS; LYMPHOCYTOSIS;

EID: 84889608334     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Cheson BD, Bennett JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol. 1988;29(3):152-163.
2. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87(12):4990-4997.
3. Vogt R F, Shim YK, Middleton DC, et al. Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol. 2007;139(5):690-700.
4. Shim YK, Vogt R F, Middleton D, et al. Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom. 2007;72(5):344-353.
5. Nieto WG, Teodosio C, López A, et al; Primary Health Care Group of Salamanca for the Study of MBL. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics. Cytom-etry B Clin Cytom. 2010;78(s1)(suppl 1):S24-S34.
6. Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659-667.
7. Marti GE, Rawstron AC, Ghia P, et al; International Familial CLL Consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130(3):325-332.
8. Hallek M, Cheson BD, Catovsky D, et al; International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446-5456.
9. Rachel JM, Zucker ML, Fox CM, et al. Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol. 2007;139(5):832-836.
10. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100(2):635-639.
11. Ghia P, Prato G, Scielzo C, et al. Monoclonal CD5+ and CD5- B-lym-phocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103(6):2337-2342.
12. Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lympho-cytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359(6):575-583.
13. Dagklis A, Fazi C, Sala C, et al. Te immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is diferent from CLL: diagnostic implications for clinical monitoring. Blood. 2009;114(1):26-32.
14. Nieto WG, Almeida J, Romero A, et al; Primary Health Care Group of Salamanca for the Study of MBL. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor fow cytometry approach. Blood. 2009;114(1):33-37.
15. Rawstron AC, Shanafelt T, Lanasa MC, et al. Diferent biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom. 2010;78(s1)(suppl 1):S19-S23.
16. Rossi D, Sozzi E, Puma A, et al. Te prognosis of clinical monoclonal B cell lymphocytosis difers from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146(1):64-75.
17. Shanafelt TD, Kay NE, Rabe KG, et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol. 2009;27(24):3959-3963.
18. Norman AD, Call TG, Hanson CA, et al. Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Olmsted county, 2000-2010: impact of the 2008 International Workshop on CLL Guidelines [AACR abstract 2287]. Cancer Res. 2013;73(8 suppl): 2287.
19. Goldin LR, Lanasa MC, Slager SL, et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol. 2010;151(2):152-158.
20. Marti GE, Carter P, Abbasi F, et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2003;52(1):1-12.
21. Rawstron AC, Yuille MR, Fuller J, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002;100(7):2289-2290.
22. Matos DM, Ismael SJ, Scrideli CA, de Oliveira FM, Rego EM, Falcão R P. Monoclonal B-cell lymphocytosis in frst-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. Br J Haematol. 2009;147(3):339-346.
23. Berndt SI, Skibola C F, Joseph V, et al. Genome-wide association study identifes multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45(8):868-876.
24. Slager SL, Camp NJ, Conde L, et al. Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol. 2012;159(5):572-576.
25. Crowther-Swanepoel D, Corre T, Lloyd A, et al. Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. Blood. 2010;116(26):5957-5960.
26. Agathangelidis A, Darzentas N, Hadzidimitriou A, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classifcation with implications for targeted therapies. Blood. 2012;119(19):4467-4475.
27. Vardi A, Dagklis A, Scarfò L, et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood. 2013;121(22):4521-4528.
28. Anderson LA, Landgren O, Engels EA. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol. 2009;147(4):444-449.
29. Landgren O, Rapkin JS, Caporaso NE, et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 2007;109(5):2198-2201.
30. Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L. Acquired immune-related and infammatory conditions and subsequent chronic lympho-cytic leukaemia. Br J Haematol. 2007;139(5):791-798.
31. Fazi C, Dagklis A, Cottini F, et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom. 2010;78(S1)(Suppl 1):S61-S68.
32. Lanasa MC, Allgood SD, Volkheimer AD, et al. Single-cell analysis reveals oligoclonal-ity among 'low-count' monoclonal B-cell lymphocytosis. Leukemia. 2010;24(1):133-140.
33. Gutierrez A Jr, Tschumper RC, Wu X, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 2010;116(16):2975-2983.
34. Molica S, Mauro FR, Giannarelli D, et al. Diferentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Hae-matologica. 2011;96(2):277-283.
35. Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: diferentiat-ing chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113(18):4188-4196.
36. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-1916.
37. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
38. Del Giudice I, Rossi D, Chiaretti S, et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profling and refne the intermediate prognosis of +12 CLL. Haematologica. 2012;97(3):437-441.
39. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fudarabine-refractoriness. Blood. 2011;118(26):6904-6908.
40. Rasi S, Monti S, Spina V, Foà R, Gaidano G, Rossi D. Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis. Haematologica. 2012;97(1):153-154.
41. Greco M, Capello D, Bruscaggin A, et al. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. Hematol Oncol. 2013;31(1):54-55.
42. Henriques A, Rodríguez-Caballero A, Nieto WG, et al. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocy-tosis versus chronic lymphocytic leukemia. PLoS ONE. 2013;8(7):e67751.
43. Gibson SE, Swerdlow SH, Ferry JA, et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica. 2011;96(8):1144-1152.
44. Muntañola A, Bosch F, Arguis P, et al. Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. J Clin Oncol. 2007;25(12):1576-1580.
45. Gentile M, Cutrona G, Fabris S, et al. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study. Am J Hematol. 2013;88(7):539-544.
46. Fazi C, Scarfò L, Pecciarini L, et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood. 2011;118(25):6618-6625.
47. Bennett FL, Dalal S, Jack AS, Hillmen P, Rawstron AC. Five-year follow-up of monoclonal B-cell lymphocytosis (MBL) in individuals with a normal blood count: expansion of the abnormal B-cell compartment but no progressive disease [ASH abstract 59]. Blood. 2009;114(22):59.
48. Fung SS, Hillier KL, Leger CS, et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma. 2007;48(6):1087-1091.
49. Kern W, Bacher U, Haferlach C, et al. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classifed as early-stage CLL. Br J Haematol. 2012;157(1):86-96.
50. Xu W, Li JY, Wu YJ, et al. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis. Leuk Res. 2009;33(12):1619-1622.
51. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24(3):512-520.
52. Shanafelt TD, Kay NE, Rabe KG, et al. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population. Leukemia. 2012;26(2):373-376.
53. Wadhwa PD, Morrison VA. Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006;33(2):240-249.
54. Francis S, Karanth M, Pratt G, et al. Te efect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer. 2006;107(5):1023-1033.
55. Kay NE. Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and defcient helper (T mu) activity with respect to B-cell proliferation. Blood. 1981;57(3):418-420.
56. Zeya HI, Keku E, Richards F II, Spurr CL. Monocyte and granulocyte defect in chronic lymphocytic leukemia. Am J Pathol. 1979;95(1):43-54.
57. Moreira J, Rabe KG, Cerhan JR, et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia. 2013;27(1):136-141.
58. Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979-1981.
59. Solomon BM, Rabe KG, Slager SL, Brewer JD, Cerhan JR, Shanafelt TD. Overall and cancer-specifc survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. J Clin Oncol. 2013;31(7):930-937.
60. Solomon BM, Rabe KG, Moreira J, et al. Risk of cancer in patients with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed patients compared to controls [ASH abstract 2893]. Blood. 2012;120(21):2893.
61. Dreger P, Corradini P, Kimby E, et al; Chronic Leukemia Working Party of the EBMT. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia. 2007;21(1):12-17.
62. Del Giudice I, Mauro FR, De Propris MS, et al. Identifcation of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients. Blood. 2009;114(13):2848-2849.
63. Pavletic SZ, Zhou G, Sobocinski K, et al; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee. Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia. 2007;21(12):2452-2455.
64. Perz JB, Ritgen M, Moos M, Ho AD, Kneba M, Dreger P. Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML. Bone Marrow Transplant. 2008;42(10):687-688.
65. Hardy NM, Grady C, Pentz R, et al. Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol. 2007;139(5):824-831.
66. Ferrand C, Garnache-Ottou F, Collonge-Rame MA, et al. Systematic donor blood qualifcation by fow cytometry would have been able to avoid CLL-type MBL transmission after unrelated hematopoietic stem cell transplantation. Eur J Haematol. 2012;88(3):269-272.